Establishing A Remote Audit Process As A CDMO
By Adara Kurtz, Quality Assurance Manager, Singota, Jerrad Tosti, Quality Assurance Supervisor, Singota, Patti Fiscus, Quality Assurance Supervisor, Singota Solutions

The effects of the pandemic have been far reaching within the pharmaceutical industry and compliance audits have not been immune. Widespread travel restrictions and adjusted visitor policies have prevented standard onsite audits from occurring. As a CDMO, Singota has excelled at providing clients with transparent and robust compliance audits. This has historically been achieved through onsite visits and face-to-face interactions. Due to current events, Singota has been required to adapt quickly to the changing environment to maintain a high level of service while protecting employee and client safety.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.